XML 55 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2014
Stock-Based Compensation Arrangements  
Schedule of stock based compensation expense

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2013     2014     2013     2014  
General and administrative   $ 82     $ 160     $ 199     $ 415  
Research and development     15       59       44       174  
Stock-based compensation costs before income taxes   $ 97     $ 219     $ 243     $ 589  
 
Schedule of stock option activity

 

    Number of
Options
Outstanding
    Weighted
Average
Exercise
Price Per Share
    Weighted
Average
Remaining
Contractual
Term (Years)
    Aggregate
Intrinsic
Value ($000)
 
Options outstanding at December 31, 2013     949,685     $ 15.02       7.38     $ 152  
Granted     63,000     $ 3.11                  
Exercised         $                  
Cancelled/forfeited     (2,387 )   $ 31.08                  
Options outstanding at September 30, 2014     1,010,298     $ 14.24       6.83     $ 7  
Unvested at September 30, 2014     449,915     $ 4.15       9.16     $ 1  
Vested and exercisable at September 30, 2014     560,383     $ 22.33       4.96     $ 6  
 
Schedule of restricted stock units activity

 

    Restricted Stock
Units (1)
    Weighted Average
Grant
Date Value Per Share
 
Non-vested at December 31, 2013     119,248     $ 5.62  
Granted         $  
Forfeited     (233 )   $ 5.39  
Non-vested at September 30, 2014     119,015     $ 5.62  

 

 
(1) Includes 85,097 restricted stock units issued that will vest upon the fulfillment of certain clinical and financial conditions.